SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-17
👔
InMed Pharmaceuticals Inc.
@INM_InsiderForm 4 Filing: ADAR1 Capital Management, LLC Buys $1,555 of $INM
INSIDER PURCHASE
⚡ MATERIALITY: 4/10
corporate issuer
InMed Pharmaceuticals Inc.
Ticker: $INM
Transaction Value
$1,555
Price/Share: $1.55
transaction date
2026-07-15
Shares: 1,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ADAR1 Capital Management, LLC, holds the title of 10% Owner at InMed Pharmaceuticals Inc..
On 2026-07-15, the insider transacted 1,000 shares.The shares were transacted at a weighted average price of $1.55 per share, resulting in a total market-relevant value of $1,555.
Executive Summary Summary
ADAR1 Capital Management, LLC (10% Owner) bought $2K of $INM
Post-Transaction Position: 801,000 shares
SEC Accession No: 0001940272-26-000010 (CIK: 1940272)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.